{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:29:58Z","timestamp":1777444198174,"version":"3.51.4"},"reference-count":257,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020247","name":"University of Bisha","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007470","name":"Shaqra University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007470","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.prp.2023.154947","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T11:46:09Z","timestamp":1699875969000},"page":"154947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Deciphering signaling pathway interplay via miRNAs in malignant pleural mesothelioma"],"prefix":"10.1016","volume":"252","author":[{"given":"Aya","family":"Salman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif S.","family":"Abdel Mageed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doaa","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud A.","family":"Elrebehy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed I.","family":"Abulsoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shereen Saeid","family":"Elshaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad Gamil","family":"Khidr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohada M.","family":"AL-Noshokaty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nehal I.","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed S.","family":"Elballal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghadir A.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai A.","family":"Abd-Elmawla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manar Mohammed","family":"El Tabaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed A.","family":"El-Husseiny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba M.","family":"Midan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walaa A.","family":"El-Dakroury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa Ahmed","family":"Abdel-Reheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed S.","family":"Doghish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prp.2023.154947_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-38552-z","article-title":"Dynamic BH3 profiling identifies pro-apoptotic drug combinations for the treatment of malignant pleural mesothelioma","volume":"14","author":"Potter","year":"2023","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.prp.2023.154947_bib2","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1136\/thoraxjnl-2021-217709","article-title":"Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study","volume":"77","author":"Kooten","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.prp.2023.154947_bib3","unstructured":"D.H. Sterman, L.A. Litzky, L.R. Kaiser, E. Valli\u00e8res, Presentation, initial evaluation, and prognosis of malignant pleural mesothelioma, UpToDate (ed Post, TW)(UpToDate, Waltham, MA, accessed 23 September 2021)."},{"issue":"5","key":"10.1016\/j.prp.2023.154947_bib4","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.3390\/ijerph18052211","article-title":"Ascertainment bias in a historic cohort study of residents in an asbestos manufacturing community","volume":"18","author":"Wortzel","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.prp.2023.154947_bib5","article-title":"WHO classification of tumours: thoracic tumours","author":"Borczuk","year":"2021","journal-title":"Int. Agency Res. Cancer"},{"key":"10.1016\/j.prp.2023.154947_bib6","first-page":"2018","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.prp.2023.154947_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154665","article-title":"miRNAs orchestration of adrenocortical carcinoma - particular emphasis on diagnosis, progression and drug resistance","author":"El-Dakroury","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib8","article-title":"The potential role of miRNAs in the pathogenesis of gallbladder cancer - a focus on signaling pathways interplay","author":"Doghish","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154684","article-title":"miRNAs orchestration of gallbladder cancer - particular emphasis on diagnosis, progression and drug resistance","author":"Shahin","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154690","article-title":"The potential role of miRNAs in the pathogenesis of adrenocortical carcinoma \u2013 a focus on signaling pathways interplay","volume":"248","author":"Midan","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154763","article-title":"miRNAs driving diagnosis, prognosis and progression in Merkel cell carcinoma","volume":"249","author":"Al-Noshokaty","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154771","article-title":"The emerging role of miRNAs in Merkel cell carcinoma pathogenesis: signaling pathway crosstalk","author":"Rizk","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154817","article-title":"Melodic maestros: Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of malignant pleural mesothelioma","volume":"250","author":"Abd-Elmawla","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154856","article-title":"Possible role of miRNAs in pheochromocytoma pathology - signaling pathways interaction","author":"Elkhawaga","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154857","article-title":"From strings to signals: Unraveling the impact of miRNAs on diagnosis, and progression of colorectal cancer","author":"Mohammed","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154855","article-title":"Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer","author":"Abulsoud","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib17","article-title":"From diagnosis to resistance: a symphony of miRNAs in pheochromocytoma progression and treatment response","author":"Elsakka","year":"2023","journal-title":"Naunyn-Schmiede 'S. Arch. Pharmacol."},{"key":"10.1016\/j.prp.2023.154947_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154375","article-title":"The role of miRNAs in liver diseases: Potential therapeutic and clinical applications","volume":"243","author":"Doghish","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib19","article-title":"miRNAs as potential game-changers in bone diseases: future medicinal and clinical Uses","author":"Doghish","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154704","article-title":"miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma","volume":"248","author":"Elkady","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154715","article-title":"Decoding the role of miRNAs in multiple myeloma pathogenesis: a focus on signaling pathways","author":"Yehia","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154613","article-title":"miRNAs orchestration of cardiovascular diseases \u2013 particular emphasis on diagnosis, and progression","volume":"248","author":"Elsakka","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154624","article-title":"The potential role of miRNAs in the pathogenesis of cardiovascular diseases \u2013 a focus on signaling pathways interplay","volume":"248","author":"Khidr","year":"2023","journal-title":"Pathol. - Res. Pract."},{"issue":"4","key":"10.1016\/j.prp.2023.154947_bib24","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/j.sjbs.2021.02.001","article-title":"MicroRNA-567 inhibits cell proliferation and induces cell apoptosis in A549 NSCLC cells by regulating cyclin-dependent kinase 8","volume":"28","author":"Elkady","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.prp.2023.154947_bib25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2147\/DMSO.S187422","article-title":"Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients","author":"Bakr Zaki","year":"2019","journal-title":"Diabetes, Metab. Syndr. Obes.: Targets Ther."},{"issue":"7","key":"10.1016\/j.prp.2023.154947_bib26","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jcjd.2020.12.005","article-title":"Circulating miR-148a-5p and miR-21-5p as novel diagnostic biomarkers in adult egyptian male patients with metabolic syndrome","volume":"45","author":"Doghish","year":"2021","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.prp.2023.154947_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154790","article-title":"The interplay between toxoplasmosis and host miRNAs: mechanisms and consequences","volume":"250","author":"Doghish","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121321","article-title":"miRNAs insights into rheumatoid arthritis: favorable and detrimental aspects of key performers","volume":"314","author":"Doghish","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154947_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154512","article-title":"Long non-coding RNAs and rheumatoid arthritis: Pathogenesis and clinical implications","author":"Elazazy","year":"2023","journal-title":"Pathol. - Res. Pract."},{"issue":"1","key":"10.1016\/j.prp.2023.154947_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2022.106978","article-title":"miRNAs as cornerstones in diabetic microvascular complications","volume":"138","author":"Ismail","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.prp.2023.154947_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123189","article-title":"The role of miRNAs in insulin resistance and diabetic macrovascular complications \u2013 a review","volume":"230","author":"Abdel Mageed","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154947_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121382","article-title":"miRNAs as cornerstones in adipogenesis and obesity","volume":"315","author":"Elkhawaga","year":"2023","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.154947_bib33","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.dsx.2018.11.058","article-title":"Plasma endoglin in Type2 diabetic patients with nephropathy","volume":"13","author":"Doghish","year":"2019","journal-title":"Diabetes Metab. Syndr.: Clin. Res. Rev."},{"issue":"10","key":"10.1016\/j.prp.2023.154947_bib34","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/cbin.11653","article-title":"miRNAs; a novel strategy for the treatment of COVID\u201019","volume":"45","author":"Ying","year":"2021","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.prp.2023.154947_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113977","article-title":"Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions","volume":"157","author":"Abulsoud","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.prp.2023.154947_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271271","article-title":"Clinical and chest computed tomography features of patients suffering from mild and severe COVID-19 at Fayoum University Hospital in Egypt","volume":"17","author":"Ismail","year":"2022","journal-title":"Plos One"},{"issue":"4","key":"10.1016\/j.prp.2023.154947_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249346","article-title":"Clinical characteristics of Egyptian male patients with COVID\u201019 acute respiratory distress syndrome","volume":"16","author":"Doghish","year":"2021","journal-title":"Plos One"},{"key":"10.1016\/j.prp.2023.154947_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112681","article-title":"MicroRNAs in Alzheimer's disease: potential diagnostic markers and therapeutic targets","volume":"148","author":"Liu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2023.154947_bib39","unstructured":"K.I. Eissa, M.M. Kamel, L.W. Mohamed, A.S. Doghish, R. Alnajjar, A.A. Al\u2010Karmalawy, A.E. Kassab, Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease, Drug Dev. Res."},{"issue":"8","key":"10.1016\/j.prp.2023.154947_bib40","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3390\/ph16081123","article-title":"Alvespimycin exhibits potential Anti-TGF-\u03b2 signaling in the setting of a proteasome activator in rats with bleomycin-induced pulmonary fibrosis: a promising novel approach","volume":"16","author":"Mohammed","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.prp.2023.154947_bib41","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.3390\/ijerph20042833","article-title":"Mesothelioma due to workplace exposure: a comprehensive bibliometric analysis of current situation and future trends","volume":"20","author":"Lai","year":"2023","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"1","key":"10.1016\/j.prp.2023.154947_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-33116-z","article-title":"Epigenetic investigation into circulating microRNA 197-3p in sera from patients affected by malignant pleural mesothelioma and workers ex-exposed to asbestos","volume":"13","author":"Di Mauro","year":"2023","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.prp.2023.154947_bib43","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/biomedicines11020538","article-title":"Small RNA-seq transcriptome profiling of mesothelial and mesothelioma cell lines revealed microRNA dysregulation after exposure to asbestos-like fibers","volume":"11","author":"Filetti","year":"2023","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.prp.2023.154947_bib44","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000528670","article-title":"miR-142-3p suppresses invasion and adhesion of mesothelioma cells by downregulating ITGAV","volume":"90","author":"Endo","year":"2023","journal-title":"Pathobiology"},{"key":"10.1016\/j.prp.2023.154947_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104043","article-title":"Targeting AXL in mesothelioma: From functional characterization to clinical implication","volume":"188","author":"Bhadresha","year":"2023","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"1","key":"10.1016\/j.prp.2023.154947_bib46","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.prp.2023.154947_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154567","article-title":"The long non-coding RNA ZFAS1 promotes colorectal cancer progression via miR200b\/ZEB1 axis","volume":"247","author":"Salman","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154570","article-title":"LncRNA NNT-AS1\/hsa-miR-485\u20135p\/HSP90 axis in-silico and clinical prospect correlated-to histologic grades-based CRC stratification: a step toward ncRNA Precision","volume":"247","author":"El-Sheikh","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2019.00626","article-title":"Circulating MicroRNAs in cancer: potential and challenge","volume":"10","author":"Cui","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.prp.2023.154947_bib50","article-title":"Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating pathway(s) and clinical outcome(s) association","volume":"240","author":"El-Sheikh","year":"2022","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.prp.2023.154947_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2022.09.209","article-title":"Interactome battling of lncRNA CCDC144NL-AS1: its role in the emergence and ferocity of cancer and beyond","author":"Abd El Fattah","year":"2022","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154947_bib52","article-title":"Defining disease-related modules based on weighted miRNA synergistic network","volume":"152","author":"Li","year":"2022","journal-title":"Comput. Biol. Med"},{"issue":"3","key":"10.1016\/j.prp.2023.154947_bib53","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ncrna.2023.03.004","article-title":"Telomerase RNA component lncRNA as potential diagnostic biomarker promotes CRC cellular migration and apoptosis evasion via modulation of \u03b2-catenin protein level","volume":"8","author":"Bakr","year":"2023","journal-title":"Non-coding RNA Res."},{"key":"10.1016\/j.prp.2023.154947_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154509","article-title":"Mitochondrial remodeling in colorectal cancer initiation, progression, metastasis, and therapy: a review","volume":"246","author":"Abdelmaksoud","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mgene.2018.11.006","article-title":"Diagnostic Significance of miR-639 and miR-10b in \u0392reast Cancer Patients","volume":"19","author":"Ismail","year":"2019","journal-title":"Meta Gene"},{"issue":"4","key":"10.1016\/j.prp.2023.154947_bib56","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.tig.2021.10.002","article-title":"Classical and noncanonical functions of miRNAs in cancers","volume":"38","author":"Dragomir","year":"2022","journal-title":"Trends Genet"},{"key":"10.1016\/j.prp.2023.154947_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120923","article-title":"Megalin, a multi-ligand endocytic receptor, and its participation in renal function and diseases: a review","volume":"308","author":"Elsakka","year":"2022","journal-title":"Life Sci."},{"issue":"7795","key":"10.1016\/j.prp.2023.154947_bib58","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41586-020-1996-3","article-title":"Loss of p53 drives neuron reprogramming in head and neck cancer","volume":"578","author":"Amit","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.prp.2023.154947_bib59","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/ng2079","article-title":"Target mimicry provides a new mechanism for regulation of microRNA activity","volume":"39","author":"Franco-Zorrilla","year":"2007","journal-title":"Nat. Genet"},{"issue":"9","key":"10.1016\/j.prp.2023.154947_bib60","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nmeth1079","article-title":"MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells","volume":"4","author":"Ebert","year":"2007","journal-title":"Nat. Methods"},{"key":"10.1016\/j.prp.2023.154947_bib61","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.addr.2014.10.029","article-title":"Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics","volume":"81","author":"Yang","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.prp.2023.154947_bib62","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ccr.2007.10.028","article-title":"p53 enters the microRNA world","volume":"12","author":"Hermeking","year":"2007","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.prp.2023.154947_bib63","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2023.154947_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120675","article-title":"Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-\u03baB pathways and LncRNA-AF085935\/GPC3 axis","author":"Al-Noshokaty","year":"2022","journal-title":"J. Life Sci."},{"key":"10.1016\/j.prp.2023.154947_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120325","article-title":"Exosomal-long non-coding RNAs journey in colorectal cancer: Evil and goodness faces of key players","volume":"292","author":"Rizk","year":"2022","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.prp.2023.154947_bib66","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bj.2020.03.001","article-title":"The role of miRNA biogenesis and DDX17 in tumorigenesis and cancer stemness","volume":"43","author":"Wu","year":"2020","journal-title":"Biomed. J."},{"issue":"6","key":"10.1016\/j.prp.2023.154947_bib67","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3390\/cells8060528","article-title":"Hypoxia- and microRNA-induced metabolic reprogramming of tumor-initiating cells","volume":"8","author":"Ullmann","year":"2019","journal-title":"Cells"},{"issue":"7014","key":"10.1016\/j.prp.2023.154947_bib68","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature03049","article-title":"Processing of primary microRNAs by the Microprocessor complex","volume":"432","author":"Denli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.prp.2023.154947_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2022.08.002","article-title":"Mitochondrial miRNAs (MitomiRs): their potential roles in breast and other cancers","author":"Erturk","year":"2022","journal-title":"Mitochondrion"},{"issue":"10","key":"10.1016\/j.prp.2023.154947_bib70","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41477-021-01000-1","article-title":"Structural basis of microRNA processing by Dicer-like 1","volume":"7","author":"Wei","year":"2021","journal-title":"Nat. Plants"},{"issue":"11","key":"10.1016\/j.prp.2023.154947_bib71","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1101\/gad.1919710","article-title":"Emerging paradigms of regulated microRNA processing","volume":"24","author":"Newman","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.prp.2023.154947_bib72","article-title":"miRNAs role in cervical cancer pathogenesis and targeted therapy: signaling pathways interplay","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154411","article-title":"The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways","author":"Abdelmaksoud","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154424","article-title":"miRNAs as potential game-changers in melanoma: a comprehensive review","author":"Abd-Allah","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib75","article-title":"Promising therapeutic potential of tumor suppressor microRNAs for malignant pleural mesothelioma","volume":"8","author":"Dixit","year":"2022","journal-title":"J. Cancer Metastas-.-. Treat."},{"issue":"1","key":"10.1016\/j.prp.2023.154947_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-02694-0","article-title":"Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism","volume":"7","author":"De Santi","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.prp.2023.154947_bib77","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/PAS.0000000000000976","article-title":"Loss of BAP1 expression in atypical mesothelial proliferations helps to predict malignant mesothelioma","volume":"42","author":"Pillappa","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154947_bib78","unstructured":"Z. Butt, Elucidating BAP1-microRNA regulatory networks in mesothelioma, University of Liverpool, 2018."},{"issue":"4","key":"10.1016\/j.prp.2023.154947_bib79","first-page":"1378","article-title":"Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer","volume":"6","author":"Edler","year":"2000","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.prp.2023.154947_bib80","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00428-022-03321-8","article-title":"Micro-RNA-215 and-375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition","volume":"481","author":"Napoli","year":"2022","journal-title":"Virchows Arch."},{"issue":"13_Supplement","key":"10.1016\/j.prp.2023.154947_bib81","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1158\/1538-7445.AM2018-523","article-title":"miR-206 inhibits pleural mesothelioma by targeting an active KRAS\/CDK4\/CCND1 pathway","volume":"78","author":"Singh","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2023.154947_bib82","article-title":"MicroRNA-92a negatively regulates neurofibromin 2 and inhibits its tumor suppressive function","author":"Alcantara","year":"2018","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.prp.2023.154947_bib83","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1515\/med-2021-0383","article-title":"MALAT1 promotes malignant pleural mesothelioma by sponging miR-141-3p","volume":"16","author":"Wang","year":"2021","journal-title":"Open Med."},{"key":"10.1016\/j.prp.2023.154947_bib84","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.omtn.2021.04.001","article-title":"MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis","volume":"24","author":"Singh","year":"2021","journal-title":"Mol. Ther. -Nucleic Acids"},{"issue":"11","key":"10.1016\/j.prp.2023.154947_bib85","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/cgt.2011.50","article-title":"EphrinA1 inhibits malignant mesothelioma tumor growth via let-7 microRNA-mediated repression of the RAS oncogene","volume":"18","author":"Khodayari","year":"2011","journal-title":"Cancer Gene Ther."},{"issue":"3","key":"10.1016\/j.prp.2023.154947_bib86","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/PPO.0b013e318258b60a","article-title":"The miR-17-92 family of microRNA clusters in development and disease","volume":"18","author":"Concepcion","year":"2012","journal-title":"Cancer J. (Sudbury, Mass. )"},{"issue":"12","key":"10.1016\/j.prp.2023.154947_bib87","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4161\/cbt.10.12.14252","article-title":"MicroRNA-21: a novel therapeutic target in human cancer","volume":"10","author":"Pan","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.prp.2023.154947_bib88","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.omtn.2021.04.001","article-title":"MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis","volume":"24","author":"Singh","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.prp.2023.154947_bib89","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9280170","article-title":"Circulating miR-132-3p as a Candidate Diagnostic Biomarker For Malignant Mesothelioma","volume":"2017","author":"Weber","year":"2017","journal-title":"Dis. Markers"},{"key":"10.1016\/j.prp.2023.154947_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00105","article-title":"Manipulating microRNAs for The Treatment Of Malignant Pleural Mesothelioma: Past, Present And Future","volume":"10","author":"Reid","year":"2020","journal-title":"Front Oncol."},{"issue":"25","key":"10.1016\/j.prp.2023.154947_bib91","doi-asserted-by":"crossref","first-page":"17300","DOI":"10.18632\/oncotarget.24644","article-title":"MiR-21 over-expression and Programmed Cell Death 4 down-regulation features malignant pleural mesothelioma","volume":"9","author":"Nicole","year":"2018","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.prp.2023.154947_bib92","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/ijc.25285","article-title":"Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma","volume":"127","author":"Gee","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2023.154947_bib93","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.21037\/tcr-21-104","article-title":"Diagnostic accuracy of circulating miR-126 for malignant pleural mesothelioma: a systematic review and meta-analysis","volume":"10","author":"Zhang","year":"2021","journal-title":"Transl. Cancer Res"},{"issue":"6","key":"10.1016\/j.prp.2023.154947_bib94","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.3892\/or.2013.2351","article-title":"Downregulation of microRNA-34 induces cell proliferation and invasion of human mesothelial cells","volume":"29","author":"Tanaka","year":"2013","journal-title":"Oncol. Rep."},{"issue":"23","key":"10.1016\/j.prp.2023.154947_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13235874","article-title":"The miR-200 Family of microRNAs: fine tuners of epithelial-mesenchymal transition and circulating cancer biomarkers","volume":"13","author":"Cavallari","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2023.154947_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110943","article-title":"MicroRNA-217: a regulator of human cancer","volume":"133","author":"Zhou","year":"2021","journal-title":"Biomed. Pharm."},{"issue":"17","key":"10.1016\/j.prp.2023.154947_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174232","article-title":"Novel Insights into miR-944 in Cancer","volume":"14","author":"Shen","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2023.154947_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.973585","article-title":"A review on the importance of miRNA-135 in human diseases","volume":"13","author":"Kadkhoda","year":"2022","journal-title":"Front Genet"},{"issue":"9","key":"10.1016\/j.prp.2023.154947_bib99","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s10038-021-00938-6","article-title":"Cancer-associated miRNAs and their therapeutic potential","volume":"66","author":"Inoue","year":"2021","journal-title":"J. Hum. Genet"},{"issue":"4","key":"10.1016\/j.prp.2023.154947_bib100","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2478\/raon-2020-0057","article-title":"The influence of genetic variability in IL1B and MIR146A on the risk of pleural plaques and malignant mesothelioma","volume":"54","author":"Piber","year":"2020","journal-title":"Radio. Oncol."},{"key":"10.1016\/j.prp.2023.154947_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2020.105700","article-title":"Mechanism of miR-222 and miR-126 regulation and its role in asbestos-induced malignancy","volume":"121","author":"Gaetani","year":"2020","journal-title":"Int J. Biochem Cell Biol."},{"issue":"1","key":"10.1016\/j.prp.2023.154947_bib102","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/modpathol.2011.144","article-title":"Epithelial-mesenchymal transition in malignant mesothelioma","volume":"25","author":"Fassina","year":"2012","journal-title":"Mod. Pathol."},{"issue":"12","key":"10.1016\/j.prp.2023.154947_bib103","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1111\/1759-7714.13678","article-title":"MiR-133a acts as a tumor suppressor in lung cancer progression by regulating the LASP1 and TGF-beta\/Smad3 signaling pathway","volume":"11","author":"Shen","year":"2020","journal-title":"Thorac. Cancer"},{"issue":"27","key":"10.1016\/j.prp.2023.154947_bib104","doi-asserted-by":"crossref","first-page":"23480","DOI":"10.18632\/oncotarget.4346","article-title":"miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma","volume":"6","author":"Williams","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.prp.2023.154947_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9030325","article-title":"MiR-7 in cancer development","volume":"9","author":"Korac","year":"2021","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.prp.2023.154947_bib106","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.ymthe.2019.05.020","article-title":"MicroRNA-215-5p treatment suppresses mesothelioma progression via the MDM2-p53-signaling axis","volume":"27","author":"Singh","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.prp.2023.154947_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00650","article-title":"MicroRNAs for the diagnosis and management of malignant pleural mesothelioma: a literature review","volume":"8","author":"Lo Russo","year":"2018","journal-title":"Front Oncol."},{"issue":"15","key":"10.1016\/j.prp.2023.154947_bib108","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1158\/1078-0432.CCR-10-3040","article-title":"Epigenetic silencing of microRNA-34b\/c plays an important role in the pathogenesis of malignant pleural mesothelioma","volume":"17","author":"Kubo","year":"2011","journal-title":"Clin. Cancer Res"},{"issue":"10","key":"10.1016\/j.prp.2023.154947_bib109","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S1470-2045(17)30596-X","article-title":"miR-16: expanding the range of molecular targets in mesothelioma","volume":"18","author":"Fennell","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2023.154947_bib110","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.2147\/OTT.S183600","article-title":"MicroRNA-195: a review of its role in cancers","volume":"11","author":"Yu","year":"2018","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.prp.2023.154947_bib111","doi-asserted-by":"crossref","unstructured":"Al Mourgi M.J., Circulating Mir-497\u20135p as a Potential Non-Invasive Molecular Marker for Diagnosis and Prognosis in, Mesothelioma 7 (2020) 141.","DOI":"10.23937\/2378-3419\/1410141"},{"key":"10.1016\/j.prp.2023.154947_bib112","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8628612","article-title":"MicroRNA signatures in malignant pleural mesothelioma effusions","volume":"2019","author":"Birnie","year":"2019","journal-title":"Dis. Markers"},{"issue":"5","key":"10.1016\/j.prp.2023.154947_bib113","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1378\/chest.12-2770","article-title":"miR-1 induces growth arrest and apoptosis in malignant mesothelioma","volume":"144","author":"Xu","year":"2013","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.prp.2023.154947_bib114","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/annonc\/mdt412","article-title":"Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma","volume":"24","author":"Reid","year":"2013","journal-title":"Ann. Oncol."},{"issue":"16","key":"10.1016\/j.prp.2023.154947_bib115","doi-asserted-by":"crossref","first-page":"12591","DOI":"10.3390\/ijms241612591","article-title":"Association of thymidylate synthase (TS) gene polymorphisms with incidence and prognosis of coronary artery disease","volume":"24","author":"Kim","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.prp.2023.154947_bib116","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.147417","article-title":"Thymidylate synthase accelerates Men1-mediated pancreatic tumor progression and reduces survival","volume":"7","author":"Vijayakurup","year":"2022","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.prp.2023.154947_bib117","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41568-022-00456-3","article-title":"Targeting CDK4 and CDK6 in cancer","volume":"22","author":"Goel","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2023.154947_bib118","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.3389\/fimmu.2020.01620","article-title":"CCND1 amplification contributes to immunosuppression and is associated with a poor prognosis to immune checkpoint inhibitors in solid tumors","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2023.154947_bib119","series-title":"Functional analysis of the Neurofibromatosis Type II tumor suppressor gene","author":"Shaw","year":"1999"},{"issue":"42","key":"10.1016\/j.prp.2023.154947_bib120","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.1038\/s41388-019-0924-1","article-title":"The Hippo pathway modulates resistance to BET proteins inhibitors in lung cancer cells","volume":"38","author":"Gobbi","year":"2019","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.prp.2023.154947_bib121","first-page":"407","article-title":"Molecular alterations in malignant pleural mesothelioma: a hope for effective treatment by targeting YAP, Targeted","volume":"17","author":"Dubois","year":"2022","journal-title":"Oncology"},{"key":"10.1016\/j.prp.2023.154947_bib122","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/635748","article-title":"MicroRNA and mRNA features of malignant pleural mesothelioma and benign asbestos-related pleural effusion","volume":"2015","author":"Ak","year":"2015","journal-title":"BioMed. Res. Int."},{"issue":"20","key":"10.1016\/j.prp.2023.154947_bib123","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.3390\/cancers13205059","article-title":"Progress on Ras\/MAPK signaling research and targeting in blood and solid cancers","volume":"13","author":"Dillon","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2023.154947_bib124","doi-asserted-by":"crossref","unstructured":"E. Fayard, G. Xue, A. Parcellier, L. Bozulic, B.A. Hemmings, Protein kinase B (PKB\/Akt), a key mediator of the PI3K signaling pathway, Phosphoinositide 3-kinase in Health and Disease: 1 (2011) 31\u201356.","DOI":"10.1007\/82_2010_58"},{"issue":"6","key":"10.1016\/j.prp.2023.154947_bib125","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.921","article-title":"The role of altered microRNA expression in premalignant and malignant head and neck lesions with epithelial origin","volume":"5","author":"Farshbaf","year":"2022","journal-title":"Health Sci. Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.154947_bib126","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.prp.2023.154947_bib127","doi-asserted-by":"crossref","first-page":"533","DOI":"10.21873\/anticanres.13145","article-title":"The role of KRAS in endometrial cancer: a mini-review","volume":"39","author":"Sideris","year":"2019","journal-title":"Anticancer Res."},{"issue":"7","key":"10.1016\/j.prp.2023.154947_bib128","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3390\/cancers15072072","article-title":"KRAS mutations are associated with shortened survival in patients with epithelioid malignant pleural mesothelioma","volume":"15","author":"Vannucchi","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2023.154947_bib129","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fonc.2020.00105","article-title":"Zandwijk, Manipulating microRNAs for the treatment of malignant pleural mesothelioma: Past, present and future","volume":"10","author":"Reid","year":"2020","journal-title":"Front. Oncol."},{"issue":"8_Supplement","key":"10.1016\/j.prp.2023.154947_bib130","first-page":"633","article-title":"Wnt signaling molecules in malignant mesothelioma cells","volume":"66","author":"Dharmarajan","year":"2006","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.prp.2023.154947_bib131","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/ijc.27746","article-title":"Frizzled homolog proteins, microRNAs and Wnt signaling in cancer","volume":"132","author":"Ueno","year":"2013","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.prp.2023.154947_bib132","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.canlet.2019.12.016","article-title":"Cisplatin unleashes Toll-like receptor 3-mediated apoptosis through the downregulation of c-FLIP in malignant mesothelioma","volume":"472","author":"Vanbervliet-Defrance","year":"2020","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.prp.2023.154947_bib133","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2741\/4917","article-title":"Emerging roles of microRNAs in the regulation of Toll-like receptor (TLR)-signaling","volume":"26","author":"Banerjee","year":"2021","journal-title":"Front. Biosci. (Landmark Ed. )"},{"issue":"17","key":"10.1016\/j.prp.2023.154947_bib134","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1158\/1078-0432.CCR-12-0599","article-title":"Role of hedgehog signaling in malignant pleural mesothelioma","volume":"18","author":"Shi","year":"2012","journal-title":"Clin. Cancer Res"},{"issue":"18","key":"10.1016\/j.prp.2023.154947_bib135","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1242\/dev.083691","article-title":"Roles for Hedgehog signaling in adult organ homeostasis and repair","volume":"141","author":"Petrova","year":"2014","journal-title":"Development"},{"issue":"1","key":"10.1016\/j.prp.2023.154947_bib136","first-page":"38","article-title":"STAT signalling in malignant mesothelioma: Is there a regulatory effect of microRNAs?","volume":"4","author":"Arzt","year":"2011","journal-title":"Memo. - Mag. Eur. Med. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2023.154947_bib137","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/17425247.2019.1598374","article-title":"Epidermal growth factor receptor (EGFR)-targeted therapies in mesothelioma","volume":"16","author":"Chia","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.prp.2023.154947_bib138","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-018-1650-0","article-title":"p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification","volume":"16","author":"Tian","year":"2018","journal-title":"J. Transl. Med"},{"issue":"10","key":"10.1016\/j.prp.2023.154947_bib139","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3390\/ph15101262","article-title":"Identification of novel cyanopyridones and pyrido [2, 3-D] pyrimidines as anticancer agents with dual VEGFR-2\/HER-2 inhibitory action: synthesis, biological evaluation and molecular docking studies","volume":"15","author":"Al-Warhi","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.prp.2023.154947_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154211","article-title":"Hydroxycitric acid reverses tamoxifen resistance through inhibition of ATP citrate lyase","volume":"240","author":"Ismail","year":"2022","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2020.108656","article-title":"Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase","volume":"160","author":"Ismail","year":"2020","journal-title":"Steroids"},{"key":"10.1016\/j.prp.2023.154947_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136336","article-title":"New theobromine derivative as apoptotic anti-triple-negative breast cancer targeting EGFR protein: CADD story","volume":"1294","author":"Eissa","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.prp.2023.154947_bib143","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1080\/14756366.2021.1901089","article-title":"Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers","volume":"36","author":"Kassab","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.prp.2023.154947_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106729","article-title":"Development of pyrolo[2,3-c]pyrazole, pyrolo[2,3-d]pyrimidine and their bioisosteres as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: synthesis, biological evaluation and molecular dynamics investigations","author":"Azmy","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"15","key":"10.1016\/j.prp.2023.154947_bib145","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.3390\/molecules28155812","article-title":"Antimicrobial, antibiofilm, and anticancer activities of syzygium aromaticum essential oil nanoemulsion","volume":"28","author":"Shehabeldine","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.prp.2023.154947_bib146","article-title":"Nanocomposite based on gold nanoparticles and carboxymethyl cellulose: synthesis, characterization, antimicrobial, and anticancer activities","volume":"77","author":"Doghish","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"46","key":"10.1016\/j.prp.2023.154947_bib147","doi-asserted-by":"crossref","first-page":"29052","DOI":"10.1039\/D1RA04345E","article-title":"Graphene oxide and its nanocomposites with EDTA or chitosan induce apoptosis in MCF-7 human breast cancer","volume":"11","author":"Doghish","year":"2021","journal-title":"RSC Adv."},{"issue":"16","key":"10.1016\/j.prp.2023.154947_bib148","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.3390\/polym14163352","article-title":"Synthesis of silver nanocomposite based on carboxymethyl cellulose: antibacterial, antifungal and anticancer activities","volume":"14","author":"Salem","year":"2022","journal-title":"Polymers"},{"issue":"1","key":"10.1016\/j.prp.2023.154947_bib149","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/14756366.2021.2015343","article-title":"New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies","volume":"37","author":"Elkady","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.prp.2023.154947_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154807","article-title":"Rumex vesicarius L. boosts the effectiveness of sorafenib in triple-negative breast cancer by downregulating BCl2, mTOR, and JNK, and upregulating p21 expression","volume":"250","author":"Ghanem","year":"2023","journal-title":"Pathol. - Res. Pract."},{"issue":"5","key":"10.1016\/j.prp.2023.154947_bib151","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ijc.10996","article-title":"Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops","volume":"104","author":"Masood","year":"2003","journal-title":"Int J. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2023.154947_bib152","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/02841860500468927","article-title":"Expression of bcl-2 family members in malignant pleural mesothelioma","volume":"45","author":"O'Kane","year":"2006","journal-title":"Acta Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154947_bib153","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1165\/ajrcmb.16.1.8998073","article-title":"Absence of p53 mutations in malignant mesotheliomas","volume":"16","author":"Mor","year":"1997","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.prp.2023.154947_bib154","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.21037\/jtd-20-2761","article-title":"Epidemiology, diagnosis and treatment of the malignant pleural mesothelioma, a narrative review of literature","volume":"13","author":"Schumann","year":"2021","journal-title":"J. Thorac. Dis."},{"issue":"7","key":"10.1016\/j.prp.2023.154947_bib155","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/14712598.2019.1606209","article-title":"Immune checkpoint inhibition for the treatment of mesothelioma","volume":"19","author":"Nowak","year":"2019","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.prp.2023.154947_bib156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11864-020-00807-y","article-title":"A review of pharmacologic management in the treatment of mesothelioma","volume":"22","author":"Borrelli","year":"2021","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.prp.2023.154947_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121364","article-title":"The neuroprotective effect of pterostilbene on oxaliplatin-induced peripheral neuropathy via its anti-inflammatory, anti-oxidative and anti-apoptotic effects: comparative study with celecoxib","volume":"315","author":"Abd-Elmawla","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154947_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106743","article-title":"Acovenoside A as a novel therapeutic approach to boost taxol and carboplatin apoptotic and antiproliferative activities in NSCLC: interplay of miR-630\/miR-181a and apoptosis genes","author":"Aborehab","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"9","key":"10.1016\/j.prp.2023.154947_bib159","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/14656566.2016.1176145","article-title":"Advances in treatment of mesothelioma","volume":"17","author":"Maggioni","year":"2016","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.prp.2023.154947_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110541","article-title":"The lncRNAs UCA1 and CRNDE target miR-145\/TLR4\/NF-\u049bB\/TNF-\u03b1 axis in acetic acid-induced ulcerative colitis model: the beneficial role of 3, 3-Diindolylmethane","volume":"121","author":"El-Boghdady","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.prp.2023.154947_bib161","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1021\/acschemneuro.2c00653","article-title":"MAGI2-AS3 and miR-374b-5p as putative regulators of multiple sclerosis via modulating the PTEN\/AKT\/IRF-3\/IFN-\u03b2 axis: new clinical insights","volume":"14","author":"Kortam","year":"2023","journal-title":"ACS Chem. Neurosci."},{"issue":"11","key":"10.1016\/j.prp.2023.154947_bib162","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22899","article-title":"Lutein exerts its cardioprotective effect against the experimental model of isoprenaline\u2010induced myocardial infarction via MIAT\/miR\u2010200a\/Nrf2\/TXINP pathway","volume":"35","author":"Abdelmonem","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.prp.2023.154947_bib163","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.biopha.2017.07.075","article-title":"Regulation of microRNA using promising dietary phytochemicals: Possible preventive and treatment option of malignant mesothelioma","volume":"94","author":"Sayeed","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"15","key":"10.1016\/j.prp.2023.154947_bib164","doi-asserted-by":"crossref","first-page":"7753","DOI":"10.1093\/nar\/gkz638","article-title":"Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer","volume":"47","author":"Lai","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10.1016\/j.prp.2023.154947_bib165","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/jphp.13351","article-title":"Recent trends in targeting miRNAs for cancer therapy","volume":"72","author":"Shah","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.prp.2023.154947_bib166","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/modpathol.2011.144","article-title":"Epithelial\u2013mesenchymal transition in malignant mesothelioma","volume":"25","author":"Fassina","year":"2012","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2023.154947_bib167","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.prp.2023.154947_bib168","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbcan.2009.03.002","article-title":"Epithelial\u2013mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic","volume":"1796","author":"Voulgari","year":"2009","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Rev. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154947_bib169","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3892\/ijo.2017.4025","article-title":"Regulation of autophagy and EMT by the interplay between p53 and RAS during cancer progression","volume":"51","author":"Zhang","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2023.154947_bib170","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1158\/0008-5472.CAN-09-3993","article-title":"hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma","volume":"70","author":"Pass","year":"2010","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.prp.2023.154947_bib171","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1158\/1078-0432.CCR-10-3040","article-title":"Epigenetic silencing of microRNA-34b\/c plays an important role in the pathogenesis of malignant pleural mesothelioma","volume":"17","author":"Kubo","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.prp.2023.154947_bib172","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.3892\/or.2013.2351","article-title":"Downregulation of microRNA-34 induces cell proliferation and invasion of human mesothelial cells","volume":"29","author":"Tanaka","year":"2013","journal-title":"Oncol. Rep."},{"issue":"30","key":"10.1016\/j.prp.2023.154947_bib173","doi-asserted-by":"crossref","first-page":"22809","DOI":"10.1074\/jbc.M110.100354","article-title":"Pro-tumorigenic effects of miR-31 loss in mesothelioma","volume":"285","author":"Ivanov","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.prp.2023.154947_bib174","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3892\/ijo.2016.3358","article-title":"Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma","volume":"48","author":"Amatya","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154947_bib175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-016-0529-z","article-title":"KCa1. 1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma","volume":"15","author":"Cheng","year":"2016","journal-title":"Mol. Cancer"},{"issue":"15","key":"10.1016\/j.prp.2023.154947_bib176","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1089\/ars.2013.5215","article-title":"MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial function","volume":"21","author":"Tomasetti","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"24","key":"10.1016\/j.prp.2023.154947_bib177","doi-asserted-by":"crossref","first-page":"36338","DOI":"10.18632\/oncotarget.8916","article-title":"MicroRNA-126 induces autophagy by altering cell metabolism in malignant mesothelioma","volume":"7","author":"Tomasetti","year":"2016","journal-title":"Oncotarget"},{"issue":"46","key":"10.1016\/j.prp.2023.154947_bib178","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1038\/onc.2013.476","article-title":"Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma","volume":"33","author":"Cioce","year":"2014","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.prp.2023.154947_bib179","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/annonc\/mdt412","article-title":"Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma","volume":"24","author":"Reid","year":"2013","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2023.154947_bib180","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jtho.2017.10.016","article-title":"Dysregulated expression of the MicroRNA miR-137 and its target YBX1 contribute to the invasive characteristics of malignant pleural mesothelioma","volume":"13","author":"Johnson","year":"2018","journal-title":"J. Thorac. Oncol."},{"issue":"27","key":"10.1016\/j.prp.2023.154947_bib181","doi-asserted-by":"crossref","first-page":"23480","DOI":"10.18632\/oncotarget.4346","article-title":"miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma","volume":"6","author":"Williams","year":"2015","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.prp.2023.154947_bib182","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jtho.2017.05.024","article-title":"Tumor suppressor microRNAs contribute to the regulation of PD-L1 expression in malignant pleural mesothelioma","volume":"12","author":"Kao","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.prp.2023.154947_bib183","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fonc.2018.00446","article-title":"miR-182 and miR-183 promote cell proliferation and invasion by targeting FOXO1 in mesothelioma","volume":"8","author":"Suzuki","year":"2018","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.prp.2023.154947_bib184","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/1878-0261.12386","article-title":"Post\u2010transcriptional regulation of PIAS 3 expression by miR\u201018a in malignant mesothelioma","volume":"12","author":"He","year":"2018","journal-title":"Mol. Oncol."},{"issue":"28","key":"10.1016\/j.prp.2023.154947_bib185","doi-asserted-by":"crossref","first-page":"25533","DOI":"10.18632\/oncotarget.4575","article-title":"Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation","volume":"6","author":"Sun","year":"2015","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.prp.2023.154947_bib186","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1093\/emboj\/cdg266","article-title":"The role of Ppe1\/PP6 phosphatase for equal chromosome segregation in fission yeast kinetochore","volume":"22","author":"Goshima","year":"2003","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.prp.2023.154947_bib187","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/ncb1258","article-title":"Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance","volume":"7","author":"MacKeigan","year":"2005","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.prp.2023.154947_bib188","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1517\/13543784.2012.668527","article-title":"PIM1 kinase as a target for cancer therapy","volume":"21","author":"Merkel","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.prp.2023.154947_bib189","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-014-0095-z","article-title":"Pim kinases in hematological malignancies: where are we now and where are we going?","volume":"7","author":"Mondello","year":"2014","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.prp.2023.154947_bib190","doi-asserted-by":"crossref","unstructured":"M. Oeggerli, Y. Tian, C. Ruiz, B. Wijker, G. Sauter, E. Obermann, U. G\u00fcth, I. Zlobec, M. Sausbier, K. Kunzelmann, Role of KCNMA1 in breast cancer, (2012).","DOI":"10.1371\/journal.pone.0041664"},{"issue":"4","key":"10.1016\/j.prp.2023.154947_bib191","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2009.02.038","article-title":"MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells","volume":"137","author":"Xu","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.prp.2023.154947_bib192","doi-asserted-by":"crossref","DOI":"10.18502\/ijaai.v19i3.3451","article-title":"Impact of OCT4 and its related signaling pathways on gastrointestinal cancers: focusing on targeted therapy","author":"Cheshomi","year":"2020","journal-title":"Iran. J. Allergy, Asthma Immunol."},{"issue":"5","key":"10.1016\/j.prp.2023.154947_bib193","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/cas.14006","article-title":"Oncogenic Y\u2010box binding protein\u20101 as an effective therapeutic target in drug\u2010resistant cancer","volume":"110","author":"Kuwano","year":"2019","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.154947_bib194","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1600-065X.2008.00662.x","article-title":"Control of peripheral T\u2010cell tolerance and autoimmunity via the CTLA\u20104 and PD\u20101 pathways","volume":"224","author":"Fife","year":"2008","journal-title":"Immunol. Rev."},{"issue":"8","key":"10.1016\/j.prp.2023.154947_bib195","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.3390\/ijms23084120","article-title":"KRAS: a druggable target in colon cancer patients","volume":"23","author":"Negri","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.prp.2023.154947_bib196","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/jmcb\/mjr013","article-title":"Applications of post-translational modifications of FoxO family proteins in biological functions","volume":"3","author":"Zhao","year":"2011","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.prp.2023.154947_bib197","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1007\/s13277-015-4425-8","article-title":"miR-411 contributes the cell proliferation of lung cancer by targeting FOXO1","volume":"37","author":"Zhao","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.prp.2023.154947_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120965","article-title":"LncRNA MEG3 regulates the interplay between Th17 and Treg cells in Beh\u00e7et's disease and systemic lupus erythematosus","volume":"309","author":"Mehana","year":"2022","journal-title":"Life Sci."},{"issue":"19","key":"10.1016\/j.prp.2023.154947_bib199","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1158\/1078-0432.CCR-14-1233","article-title":"Low PIAS3 expression in malignant mesothelioma is associated with increased STAT3 activation and poor patient survival","volume":"20","author":"Dabir","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.prp.2023.154947_bib200","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/cam4.372","article-title":"PIAS3 expression in squamous cell lung cancer is low and predicts overall survival","volume":"4","author":"Abbas","year":"2015","journal-title":"Cancer Med."},{"key":"10.1016\/j.prp.2023.154947_bib201","doi-asserted-by":"crossref","unstructured":"C.M.Croce, Causes and consequences of microRNA dysregulation in cancer 10 (10) (2009) 704\u2013714.","DOI":"10.1038\/nrg2634"},{"key":"10.1016\/j.prp.2023.154947_bib202","first-page":"167","volume":"60","author":"Garzon","year":"2009","journal-title":"Micro Cancer"},{"key":"10.1016\/j.prp.2023.154947_bib203","doi-asserted-by":"crossref","unstructured":"D. Hanahan, R.A. Weinberg, Hallmarks of cancer: the next, generation 144 (5) (2011) 646\u2013674.","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"10.1016\/j.prp.2023.154947_bib204","doi-asserted-by":"crossref","unstructured":"J. Lu, G. Getz, E.A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B.L. Ebert, R.H. Mak, A.A. Ferrando, MicroRNA expression profiles classify human, cancers 435 (7043) (2005) 834\u2013838.","DOI":"10.1038\/nature03702"},{"key":"10.1016\/j.prp.2023.154947_bib205","doi-asserted-by":"crossref","unstructured":"J.C. Henry, A.C.P. Azevedo-Pouly, T.D. Schmittgen, MicroRNA replacement therapy for cancer 28 (2011) 3030\u20133042.","DOI":"10.1007\/s11095-011-0548-9"},{"key":"10.1016\/j.prp.2023.154947_bib206","doi-asserted-by":"crossref","unstructured":"G. Reid, M. Pel, M. Kirschner, Y.Y. Cheng, N. Mugridge, J. Weiss, M. Williams, C. Wright, J. Edelman, M.Vallely, Restoring expression of miR-16: a novel approach to therapy for malignant pleural, mesothelioma 24 (12) (2013) 3128\u20133135.","DOI":"10.1093\/annonc\/mdt412"},{"issue":"6","key":"10.1016\/j.prp.2023.154947_bib207","first-page":"398","article-title":"Role of anti-oncomirs miR-143 and-145 in human colorectal tumors","volume":"17","author":"Akao","year":"2010"},{"key":"10.1016\/j.prp.2023.154947_bib208","doi-asserted-by":"crossref","unstructured":"F. Takeshita, L. Patrawala, M. Osaki, R.-U. Takahashi, Y. Yamamoto, N. Kosaka, M. Kawamata, K. Kelnar, A.G. Bader, D. Brown, Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle, genes 18 (1) (2010) 181\u2013187.","DOI":"10.1038\/mt.2009.207"},{"issue":"14","key":"10.1016\/j.prp.2023.154947_bib209","first-page":"5923","article-title":"Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34","volume":"70","author":"Wiggins","year":"2010"},{"key":"10.1016\/j.prp.2023.154947_bib210","doi-asserted-by":"crossref","unstructured":"B. Johnson, L. Zhuang, E.M. Rath, M.L. Yuen, N.C. Cheng, H. Shi, S. Kao, G. Reid, Y.Y. Cheng, Exploring MicroRNA and Exosome Involvement in Malignant Pleural Mesothelioma, Drug Response 14 (19) (2022) 4784.","DOI":"10.3390\/cancers14194784"},{"key":"10.1016\/j.prp.2023.154947_bib211","doi-asserted-by":"crossref","unstructured":"J.A. MacDiarmid, N.B. Mugridge, J.C. Weiss, L. Phillips, A.L. Burn, R.P. Paulin, J.E. Haasdyk, K.-A. Dickson, V.N. Brahmbhatt, S.T. Pattison, Bacterially derived 400 nm particles for encapsulation and cancer cell targeting, of chemotherapeutics 11 (5) (2007) 431\u2013445.","DOI":"10.1016\/j.ccr.2007.03.012"},{"issue":"15_Supplement","key":"10.1016\/j.prp.2023.154947_bib212","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1158\/1538-7445.AM2015-3976","article-title":"Abstract 3976: Targeted delivery of a synthetic microRNA-based mimic as an approach to cancer therapy","volume":"75","author":"Reid","year":"2015","journal-title":"Cancer Res."},{"issue":"34","key":"10.1016\/j.prp.2023.154947_bib213","doi-asserted-by":"crossref","first-page":"36675","DOI":"10.18632\/oncotarget.5383","article-title":"MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma","volume":"6","author":"Glover","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2023.154947_bib214","doi-asserted-by":"crossref","unstructured":"D. Zhang, H. Lee, X. Wang, A. Rai, M. Groot, Exosome-mediated small RNA delivery: a novel therapeutic approach for inflammatory lung responses 26 (9) (2018) 2119\u20132130.","DOI":"10.1016\/j.ymthe.2018.06.007"},{"key":"10.1016\/j.prp.2023.154947_bib215","doi-asserted-by":"crossref","unstructured":"O. Fortunato, M. Boeri, C. Verri, M. Moro, G. Sozzi, Therapeutic use of microRNAs in lung cancer, 2014 (2014).","DOI":"10.1155\/2014\/756975"},{"key":"10.1016\/j.prp.2023.154947_bib216","doi-asserted-by":"crossref","unstructured":"M.B. Kirschner, Y.Y. Cheng, B. Badrian, S.C. Kao, J. Creaney, J.J.B. Edelman, N.J. Armstrong, M.P. Vallely, A.W. Musk, B.W. Robinson, Increased circulating miR-625\u20133p: a potential biomarker for patients with malignant pleural mesothelioma 7 (7) (2012) 1184\u20131191.","DOI":"10.1097\/JTO.0b013e3182572e83"},{"key":"10.1016\/j.prp.2023.154947_bib217","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.canlet.2017.04.007","article-title":"microRNAs as cancer therapeutics: a step closer to clinical application","volume":"407","author":"Catela Ivkovic","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2023.154947_bib218","doi-asserted-by":"crossref","unstructured":"M. Sell, C.A. Ramlogan-Steel, J.C. Steel, B.P. Dhungel, MicroRNAs in cancer metastasis: biological and therapeutic implications, (2023) 1\u201332.","DOI":"10.1017\/erm.2023.7"},{"key":"10.1016\/j.prp.2023.154947_bib219","doi-asserted-by":"crossref","unstructured":"R. Bichi, S.A. Shinton, E.S. Martin, A. Koval, G.A. Calin, R. Cesari, G. Russo, R.R. Hardy, C.M. Croce, Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression 99 (10) (2002) 6955\u20136960.","DOI":"10.1073\/pnas.102181599"},{"key":"10.1016\/j.prp.2023.154947_bib220","doi-asserted-by":"crossref","unstructured":"A. Cimmino, G.A. Calin, M. Fabbri, M.V. Iorio, M. Ferracin, M. Shimizu, S.E. Wojcik, R.I. Aqeilan, S. Zupo, M. Dono, miR-15 and miR-16 induce apoptosis by, targeting BCL2, 102(39) (2005) 13944\u201313949.","DOI":"10.1073\/pnas.0506654102"},{"key":"10.1016\/j.prp.2023.154947_bib221","doi-asserted-by":"crossref","unstructured":"D. Bonci, V. Coppola, M. Musumeci, A. Addario, R. Giuffrida, L. Memeo, L. D\u2019urso, A. Pagliuca, M. Biffoni, C. Labbaye, The miR-15a\u2013miR-16\u20131 cluster controls prostate cancer by targeting multiple oncogenic, activities 14 (11) (2008) 1271\u20131277.","DOI":"10.1038\/nm.1880"},{"key":"10.1016\/j.prp.2023.154947_bib222","doi-asserted-by":"crossref","unstructured":"N. Bandi, S. Zbinden, M. Gugger, M. Arnold, V. Kocher, L. Hasan, A. Kappeler, T. Brunner, E. Vassella, miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non\u2013small cell lung cancer 69 (13) (2009) 5553\u20135559.","DOI":"10.1158\/0008-5472.CAN-08-4277"},{"key":"10.1016\/j.prp.2023.154947_bib223","unstructured":"T. Ueno, S. Toyooka, T. Fukazawa, T. Kubo, J. Soh, H. Asano, T. Muraoka, N. Tanaka, Y. Maki, K. Shien, Preclinical evaluation of microRNA-34b\/c delivery for malignant pleural, mesothelioma 68 (1) (2014) 23\u201326."},{"key":"10.1016\/j.prp.2023.154947_bib224","doi-asserted-by":"crossref","unstructured":"D. Ovcharenko, K. Kelnar, C. Johnson, N. Leng, D.J.Cr Brown, Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway, 67(22) (2007) 10782\u201310788.","DOI":"10.1158\/0008-5472.CAN-07-1484"},{"key":"10.1016\/j.prp.2023.154947_bib225","doi-asserted-by":"crossref","unstructured":"H. Nakano, Y. Yamada, T. Miyazawa, T. Yoshida, Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer, cells 42 (6) (2013) 1875\u20131882.","DOI":"10.3892\/ijo.2013.1896"},{"issue":"13","key":"10.1016\/j.prp.2023.154947_bib226","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1089\/scd.2011.0695","article-title":"MicroRNA-193 pro-proliferation effects for bone mesenchymal stem cells after low-level laser irradiation treatment through inhibitor of growth family, member 5","volume":"21","author":"Wang","year":"2012","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.prp.2023.154947_bib227","doi-asserted-by":"crossref","unstructured":"M. Khordadmehr, R. Shahbazi, S. Sadreddini, B. Baradaran, miR\u2010193: a new weapon against cancer 234 (10) (2019) 16861\u201316872.","DOI":"10.1002\/jcp.28368"},{"issue":"1","key":"10.1016\/j.prp.2023.154947_bib228","first-page":"58","article-title":"A link between the fibroblast growth factor axis and the miR\u201016 family reveals potential new treatment combinations in mesothelioma","volume":"12","author":"Schelch","year":"2018"},{"key":"10.1016\/j.prp.2023.154947_bib229","doi-asserted-by":"crossref","unstructured":"F. Monaco, S. Gaetani, F. Alessandrini, A. Tagliabracci, M. Bracci, M. Valentino, J. Neuzil, M. Amati, M. Bovenzi, M. Tomasetti, Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: Role of miR-126 in cancer-stroma communication, 463 (2019) 27\u201336.","DOI":"10.1016\/j.canlet.2019.08.001"},{"key":"10.1016\/j.prp.2023.154947_bib230","doi-asserted-by":"crossref","unstructured":"T.G. Johnson, K. Schelch, Y.Y. Cheng, M. Williams, K.H. Sarun, M.B. Kirschner, S. Kao, A. Linton, S. Klebe, B.C. McCaughan, Dysregulated expression of the MicroRNA miR-137 and its target YBX1 contribute to the invasive characteristics of malignant pleural mesothelioma 13 (2) (2018) 258\u2013272.","DOI":"10.1016\/j.jtho.2017.10.016"},{"key":"10.1016\/j.prp.2023.154947_bib231","doi-asserted-by":"crossref","unstructured":"A. Singh, N. Bhattacharyya, A. Srivastava, N. Pruett, R.T. Ripley, D.S. Schrump, C.D. Hoang, MicroRNA-215\u20135p treatment suppresses mesothelioma progression via the MDM2-p53-signaling axis 27 (9) (2019) 1665\u20131680.","DOI":"10.1016\/j.ymthe.2019.05.020"},{"key":"10.1016\/j.prp.2023.154947_bib232","doi-asserted-by":"crossref","unstructured":"A. Singh, N. Pruett, R. Pahwa, A.P. Mahajan, D.S. Schrump, C.D. Hoang, MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis 24 (2021) 669\u2013681.","DOI":"10.1016\/j.omtn.2021.04.001"},{"issue":"5","key":"10.1016\/j.prp.2023.154947_bib233","first-page":"1632","article-title":"miR-1 induces growth arrest and apoptosis in malignant mesothelioma","volume":"144","author":"Xu","year":"2013"},{"key":"10.1016\/j.prp.2023.154947_bib234","doi-asserted-by":"crossref","unstructured":"A.S. Tsao, I. Wistuba, J.A. Roth, Malignant pleural mesothelioma 27 (12) (2009) 2081.","DOI":"10.1200\/JCO.2008.19.8523"},{"issue":"1","key":"10.1016\/j.prp.2023.154947_bib235","article-title":"Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma","volume":"4","author":"Hudson","year":"2014"},{"issue":"12_Supplement_2","key":"10.1016\/j.prp.2023.154947_bib236","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.TARG-15-C43","article-title":"Abstract C43: Safety, tolerability, and clinical activity of MRX34, the first-in-class liposomal miR-34 mimic, in patients with advanced solid tumors","volume":"14","author":"Beg","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.prp.2023.154947_bib237","doi-asserted-by":"crossref","unstructured":"D.S. Hong, Y.-K. Kang, M. Borad, J. Sachdev, S. Ejadi, H.Y. Lim, A.J. Brenner, K. Park, J.-L. Lee, T. Kim, Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid, tumours 122 (11) (2020) 1630\u20131637.","DOI":"10.1038\/s41416-020-0802-1"},{"issue":"10","key":"10.1016\/j.prp.2023.154947_bib238","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S1470-2045(17)30621-6","article-title":"Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study","volume":"18","author":"van Zandwijk","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2023.154947_bib239","doi-asserted-by":"crossref","unstructured":"G. Reid, S.C. Kao, N. Pavlakis, H. Brahmbhatt, J. MacDiarmid, S. Clarke, M. Boyer, N..v. Zandwijk, Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer, 8(8) (2016) 1079\u20131085. \u300810.2217\/epi-2016\u20130035\u3009.","DOI":"10.2217\/epi-2016-0035"},{"key":"10.1016\/j.prp.2023.154947_bib240","doi-asserted-by":"crossref","unstructured":"J.A. MacDiarmid, H. Brahmbhatt, Minicells: versatile vectors for targeted drug or si\/shRNA cancer, therapy 22 (6) (2011) 909\u2013916.","DOI":"10.1016\/j.copbio.2011.04.008"},{"issue":"12","key":"10.1016\/j.prp.2023.154947_bib241","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144559","article-title":"A first-time-in-human phase I clinical trial of bispecific antibody-targeted, paclitaxel-packaged bacterial minicells","volume":"10","author":"Solomon","year":"2015","journal-title":"PLOS One"},{"issue":"12","key":"10.1016\/j.prp.2023.154947_bib242","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.jocn.2015.06.005","article-title":"First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma","volume":"22","author":"Whittle","year":"2015","journal-title":"J. Clin. Neurosci."},{"issue":"8","key":"10.1016\/j.prp.2023.154947_bib243","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.nano.2016.06.004","article-title":"Ligand-targeted bacterial minicells: Futuristic nano-sized drug delivery system for the efficient and cost effective delivery of shRNA to cancer cells","volume":"12","author":"Jivrajani","year":"2016","journal-title":"Nanomed.: Nanotechnol., Biol. Med."},{"key":"10.1016\/j.prp.2023.154947_bib244","unstructured":"T. Kim, C.M. Croce, MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies, (2023) 1\u20138."},{"key":"10.1016\/j.prp.2023.154947_bib245","doi-asserted-by":"crossref","unstructured":"L. Liang, X. He, A narrative review of microRNA therapeutics: Understanding the future of microRNA, research 4 (2021) 33.","DOI":"10.21037\/pcm-21-28"},{"issue":"Suppl 1","key":"10.1016\/j.prp.2023.154947_bib246","article-title":"An innovative mesothelioma treatment based on miR-16 mimic loaded EGFR targeted minicells (TargomiRs)","volume":"7","author":"Viteri","year":"2018","journal-title":"Transl. Lung Cancer Res"},{"key":"10.1016\/j.prp.2023.154947_bib247","article-title":"Design, optimization, and in-vivo performance of glipizide-loaded O-carboxymethyl chitosan nanoparticles in insulin resistant\/type 2 diabetic rat model","volume":"79","author":"El-Dakroury","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.prp.2023.154947_bib248","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s11095-021-03126-5","article-title":"Olmesartan niosomes ameliorates the Indomethacin-induced gastric ulcer in rats: insights on MAPK and Nrf2\/HO-1 signaling pathway","volume":"38","author":"Sallam","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.prp.2023.154947_bib249","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154612","article-title":"miRNAs orchestration of testicular germ cell tumors-Particular emphasis on diagnosis, progression and drug resistance","author":"Elesawy","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154947_bib250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123224","article-title":"Chitosan coated clove oil-based nanoemulsion: An attractive option for oral delivery of leflunomide in rheumatoid arthritis","volume":"643","author":"Zewail","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.prp.2023.154947_bib251","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101095","article-title":"GMP-grade nanoparticle targeted to nucleolin downregulates tumor molecular signature, blocking growth and invasion, at low systemic exposure","volume":"37","author":"Fonseca","year":"2021","journal-title":"Nano Today"},{"issue":"2","key":"10.1016\/j.prp.2023.154947_bib252","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1517\/17425247.2013.744964","article-title":"Novel polyethylenimine-derived nanoparticles for in vivo gene delivery","volume":"10","author":"Patnaik","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"issue":"12","key":"10.1016\/j.prp.2023.154947_bib253","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/cgt.2009.35","article-title":"WT1 gene silencing by aerosol delivery of PEI\u2013RNAi complexes inhibits B16-F10 lung metastases growth","volume":"16","author":"Zamora-Avila","year":"2009","journal-title":"Cancer gene Ther."},{"issue":"2","key":"10.1016\/j.prp.2023.154947_bib254","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jconrel.2013.05.015","article-title":"Systemic delivery of sticky siRNAs targeting the cell cycle for lung tumor metastasis inhibition","volume":"170","author":"Bonnet","year":"2013","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.prp.2023.154947_bib255","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jconrel.2009.06.019","article-title":"Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery","volume":"140","author":"Taratula","year":"2009","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.prp.2023.154947_bib256","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139136","article-title":"Aptamer-dendrimer bioconjugates for targeted delivery of miR-34a expressing plasmid and antitumor effects in non-small cell lung cancer cells","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.prp.2023.154947_bib257","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823006489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823006489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T07:04:02Z","timestamp":1759734242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823006489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":257,"alternative-id":["S0344033823006489"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154947","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering signaling pathway interplay via miRNAs in malignant pleural mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154947"}}